Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Pfizer Biopharma JV To Go Public In $780M SPAC Union (<em>Law360</em>)

Pfizer Biopharma JV To Go Public In $780M SPAC Union (Law360)

Related Content

CFPB Issues Final Rule Requiring Standard Mortgage Disclosures for PACE Loans and Certain Other Home Improvement Financing

CFPB Issues Final Rule on Overdraft Fees

Weekly News Roundup: CFPB Finalizes Rule to Supervise Popular Digital Payment Apps

CFPB Issues Final Rule to Supervise the Largest Nonbank Companies Offering Digital Funds Transfer and Payment Wallet Apps

CFPB Report Identifies Areas for Improvement in State Data Privacy Laws

Acting Comptroller Discusses Frameworks to Identify Systemic Risk

CFPB Finalizes Personal Financial Data Rights Rule

California Expands Scope of Rosenthal Act to Cover Commercial Financial Transactions

The Chemours Company Completes Private Offering of $600,000,000 Aggregate Principal Amount of 8.000% Senior Unsecured Notes Due 2033

Goodwin Represents Underwriters on ImmunityBio’s $100.0 Million Public Offering

Goodwin Represents the Initial Purchasers on Galaxy Digital’s $402.5 Million 2.500% Exchangeable Senior Notes Offering

Goodwin Represents the Initial Purchasers on Bitdeer’s $400 Million 5.25% Convertible Senior Notes Offering

Goodwin Advises TELA on $46 Million Underwritten Public Offering of Common Stock

VSE Completes $172.5 Million Public Offering

Zip Closes $190 Million Series D, Largest Funding Round in AI-Powered Procurement Orchestration Sector

Goodwin Advises Underwriting Syndicate in The Pennant Group’s $124.7 Million Public Offering

Life Sciences

Private Equity

Capital Markets

Life Sciences IPOs & Capital Markets

Mergers & Acquisitions

Special Purpose Acquisition Companies (SPACs)